LSJ | Pluvicto | VA Phoenix Healthcare System 36C262-26-AP-0681
Summary
AI-generated · Jan 09, 2026Pluvicto for the VA Phoenix Healthcare System is being procured under a Limited Sources Justification, with Novartis Pharmaceuticals Corporation named as the awardee. The award notice lists two actions: one for $0 and one for $4,984,371, both related to Pluvicto for VA Phoenix.
The attached LSJ indicates limited competition for this procurement, implying a sole-source or restricted sourcing to the brand-name product from Novartis. This is a brand-name specific purchase, and bidders should review the LSJ for the justification details and any implications for future opportunities or requirements.
See attached Limited Sources Justification (LSJ)
From Justification posted on Jan 08, 2026Notice history
2-
Justification Posted Jan 08, 2026
-
Award Notice LATEST Posted Jan 08, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | NG61ZA8TADW3 | 04520 | East Hanover, NJ |
Contacts
Agency
Place of Performance
USA